viral
respiratori
tract
infect
common
trigger
signific
asthma
exacerb
upper
respiratori
tract
infect
uri
involv
upper
respiratori
tract
human
rhinoviru
hrv
caus
common
cold
viru
like
trigger
asthma
exacerb
contrast
usual
spring
summer
temper
zone
pollen
season
viral
tion
begin
peak
fall
number
speci
typic
cours
viral
respiratori
tract
infect
trigger
asthma
vari
person
age
acut
sinus
asthma
exacerb
associ
viral
respiratori
tract
infect
therefor
antibiot
rare
need
uncompl
case
sulfur
dioxid
nitrogen
dioxid
ozon
particul
matter
air
pollut
may
exacerb
asthma
patient
caution
stay
indoor
level
irrit
high
indoor
air
pollut
especi
tobacco
smoke
reduc
benefit
asthma
patient
introduct
health
care
provid
treat
patient
respiratori
diseas
often
ask
patient
caus
asthma
caus
asthma
suddenli
becom
wors
question
alway
difficult
answer
move
directli
discuss
manag
asthma
much
easier
road
take
recent
year
though
enough
inform
accumul
caus
asthma
one
weav
stori
contain
use
advic
may
help
patient
particip
manag
diseas
also
recent
studi
provid
answer
question
pose
physician
watch
puzzlement
previous
wellcontrol
asthma
patient
spiral
rapidli
control
stori
grow
increasingli
complex
everexpand
cast
player
sometim
creat
tangl
web
interact
chapter
look
viral
infect
air
pollut
possibl
nanoparticl
may
act
causal
agent
asthma
concept
causal
agent
though
varieti
differ
interpret
gener
agent
may
act
respiratori
tract
initi
asthma
exacerb
initi
incept
develop
asthma
refer
start
asthma
patient
previous
entir
free
problem
exacerb
trigger
precipit
event
mean
signific
often
sudden
worsen
establish
chronic
asthmat
condit
avoid
proven
initi
factor
possibl
could
permit
primari
prevent
asthma
contrast
avoid
trigger
event
halt
diseas
decreas
number
exacerb
someon
alreadi
chronic
ill
studi
treat
asthma
identif
specif
trigger
usual
much
easier
tri
prove
initi
caus
virus
affect
asthma
act
complex
vari
phenotyp
therefor
outcom
infect
quit
vari
simpl
linear
causeandeffect
relationship
viral
infect
asthmat
episod
usual
exist
koch
modifi
postul
infectioncaus
diseas
microorgan
must
present
everi
case
diseas
microorgan
must
isol
diseas
organ
grown
pure
cultur
cultur
microorgan
caus
diseas
introduc
healthi
organ
microorgan
must
recov
inocul
diseas
experiment
host
linear
way
look
viralinduc
diseas
comprehens
enough
allow
suffici
insight
relationship
viral
ill
asthma
one
viral
infect
consist
caus
asthma
even
individu
system
biolog
though
provid
conceptu
framework
better
understand
virusasthma
interact
system
biolog
look
web
factor
initi
state
individu
patient
examin
one
extern
intern
influenc
perturb
state
fig
path
taken
system
illustr
one
factor
exampl
simpl
rhinoviru
infect
may
littl
longterm
effect
mucos
inflamm
individu
atop
stressor
genet
propens
toward
asthma
individu
return
quickli
equilibrium
low
inflammatori
state
path
system
b
illustr
multipl
stressor
includ
genet
factor
atop
immun
develop
may
interact
viral
infect
caus
long
last
perhap
perman
chang
level
mucos
inflamm
detail
risk
factor
outlin
discuss
chapter
system
biolog
system
medicin
yet
specifi
featur
set
interact
way
lead
firm
predict
asthma
complex
system
approach
though
simpl
compact
principl
emerg
everi
precondit
known
predict
outcom
intervent
treatment
gener
factor
appear
import
asthmat
respons
viral
infect
includ
though
twodimension
paper
allow
multidimension
map
walk
branch
path
narr
fashion
show
interact
factor
import
viralcaus
asthma
twentieth
centuri
offic
hospit
diagnosi
viral
respiratori
infect
often
good
guess
probabl
statement
common
afford
viral
molecular
diagnost
especi
revers
transcriptas
pcr
rtpcr
viral
cultur
improv
accuraci
guess
precis
need
virus
may
detect
symptomat
asymptomat
patient
two
third
acut
respiratori
tract
infect
rti
occur
commun
identifi
viral
tradit
divid
upper
lower
rti
differ
upper
lower
infect
seem
indistinct
previous
believ
human
rhinoviru
hrv
exampl
replic
initi
upper
respiratori
tract
yet
may
caus
extens
lower
respiratori
tract
ill
frequent
use
term
viral
upper
rti
urti
somewhat
misnom
commonli
occur
respiratori
viru
hrv
account
nearli
half
case
viral
respiratori
ill
follow
influenza
viru
coronaviru
lesser
contribut
parainfluenza
viru
respiratori
syncyti
viru
rsv
adenoviru
metapneumoviru
miscellan
viral
speci
see
tabl
three
main
type
virus
known
affect
asthma
hrv
rsv
influenza
peak
period
viral
infect
tend
vari
year
year
gener
north
america
rhinoviru
peak
fall
earli
spring
influenza
earli
winter
rsv
midwint
fig
mani
commun
monitor
progress
annual
epidem
viral
cultur
molecular
diagnost
therebi
give
physician
higher
probabl
know
advanc
viru
patient
may
molecular
diagnost
panel
commerci
avail
identifi
acut
viral
respiratori
infect
though
costeffect
type
test
routin
clinic
use
yet
determin
detail
immunobiolog
major
asthmogen
viral
infect
hrv
reveal
past
sever
year
intercellular
adhes
molecul
found
nasal
epitheli
cell
attach
point
major
serotyp
hrv
hrv
divid
clade
strain
hrva
hrvb
hrvc
hrvc
proven
extrem
difficult
cultur
differ
serotyp
viral
speci
influenc
asthma
variou
age
group
differ
way
age
marker
develop
matur
immun
system
diversifi
greatli
time
human
bodi
age
immun
system
mold
environ
becom
mirror
imag
specif
usual
protein
molecul
extern
local
surround
age
also
import
effect
physic
scale
respiratori
system
airway
resist
invers
proport
fourth
power
diamet
enlarg
age
young
adulthood
slowli
declin
small
increas
airway
diamet
therefor
lead
huge
reduct
airway
resist
give
breath
room
signific
prolong
wheez
episod
children
trigger
respiratori
virus
hrv
often
involv
common
rhinoviru
cold
account
larg
part
fall
season
peak
asthma
schoolag
children
epidemiolog
evid
combin
viral
molecular
diagnosi
suggest
peak
consequ
children
return
classroom
subsequ
spread
respiratori
virus
mainli
rhinovirus
viral
exacerb
asthma
tend
prolong
sever
trigger
gust
pollenladen
breez
may
amelior
move
young
patient
indoor
exercis
trigger
remov
stop
exercis
viral
trigger
usual
steadi
persist
replic
within
bodi
studi
children
age
year
asthma
conclud
asthma
exacerb
greater
sever
viral
infect
present
oppos
nonvir
ill
airway
hyperreact
correspond
cough
wheez
may
note
well
week
rhinoviru
infect
asthmat
child
atopi
confer
addit
risk
asthmat
children
becom
ill
respiratori
viru
infect
schoolag
children
atop
asthma
oppos
nonatop
asthma
note
number
studi
experi
frequent
symptomat
cold
episod
viraltrigg
asthma
prolong
airway
hyperreact
cold
tendenc
higher
number
symptomat
rti
longer
durat
ill
also
note
allerg
children
gener
without
asthma
parent
children
atopi
asthma
tend
frustrat
prolong
recoveri
time
compar
nonatop
sibl
school
absenc
problemat
inhal
corticosteroid
leukotrien
receptor
antagonist
ltra
well
known
control
number
wheez
exacerb
schoolag
children
chronic
persist
asthma
effect
appear
encompass
episod
caus
viral
ill
survey
school
children
ontario
found
children
present
septemb
emerg
depart
asthma
exacerb
presum
mostli
viral
trigger
less
like
use
prevent
antiinflammatori
medic
counterpart
sever
exacerb
retrospect
studi
suggest
inhal
fluticason
salmeterol
administ
prior
fall
could
reduc
morbid
fall
viral
season
patient
asthma
trial
montelukast
ad
usual
asthma
therapi
abl
attenu
fall
asthma
peak
one
studi
though
effect
reach
statist
signific
later
trial
inhal
corticosteroid
might
expect
prevent
viralinduc
wheez
children
minim
chronic
diseas
well
prevent
effect
though
consist
shown
clinic
trial
studi
conduct
schoolag
children
without
persist
diseas
histori
viraltrigg
wheez
demon
strate
inhal
beclomethason
dipropon
superior
placebo
reduc
futur
episod
inhal
steroid
fail
reduc
day
symptom
frequenc
sever
durat
episod
upper
lower
respiratori
ill
prevent
medic
therefor
target
especi
patient
persist
chronic
asthma
acut
treatment
viralprovok
asthma
exacerb
oral
system
corticosteroid
continu
effect
choic
part
current
therapi
protocol
use
highdos
acut
corticosteroid
inhal
continu
studi
vari
success
whether
vaccin
prevent
asthma
exacerb
unclear
expert
panel
report
conclud
influenza
vaccin
reduc
frequenc
sever
asthma
exacerb
influenza
season
mani
patient
commun
asthma
experi
sever
complic
influenza
infect
reason
mean
prevent
still
taken
includ
vaccin
influenza
viru
appear
less
potent
trigger
asthma
hrv
influenza
peak
well
correl
childhood
asthma
peak
case
hrv
oral
influenza
antivir
oseltamivir
improv
pulmonari
function
reduc
exacerb
frequenc
one
random
placebocontrol
trial
schoolag
asthmat
children
influenza
unfortun
increas
resist
influenza
viru
antivir
agent
limit
use
longterm
strategi
reduc
ill
asthmat
children
concept
use
antivir
reduc
asthma
morbid
children
seem
theoret
promis
preschool
year
lay
groundwork
later
asthma
issu
type
discuss
diagnos
viraltrigg
asthma
infant
preschool
children
though
must
done
caution
asthma
defin
chronic
diseas
sever
even
mani
selflimit
acut
wheez
ill
necessarili
add
chronic
ill
often
children
age
group
experi
wheez
associ
varieti
viral
infect
parent
natur
anxiou
treatment
prognosi
children
preschool
children
experi
rsvand
hrvinduc
wheez
like
develop
asthma
later
year
childhood
origin
asthma
studi
coast
show
viral
wheez
ill
infanc
earli
childhood
caus
hrv
signific
predictor
subsequ
develop
asthma
age
bidirect
causat
propos
rsv
sever
rsv
associ
shortterm
increas
bronchial
hyperrespons
turn
presenc
asthma
associ
longterm
increas
suscept
sever
rsv
diseas
whether
earli
childhood
viral
infect
initi
seri
event
lead
asthma
area
much
interest
studi
one
analysi
show
infant
reach
month
age
winter
viru
peak
increas
risk
develop
later
asthma
compar
reach
age
year
winter
peak
virus
initi
asthma
patient
prevent
rsv
hrv
similar
ill
critic
time
period
might
prevent
reduc
frequenc
asthma
later
year
nonatop
infant
receiv
palivizumab
human
mab
rsv
prevent
rsv
infect
show
reduct
risk
recurr
wheez
age
though
effect
note
atop
children
hypothesi
earli
viral
infect
lead
asthma
made
less
convinc
epidemiolog
studi
show
frequent
exposur
viral
rti
throughout
earli
childhood
may
actual
decreas
risk
later
asthma
studi
unit
state
unit
kingdom
shown
day
care
attend
factor
increas
frequenc
viral
rti
reduc
risk
later
year
frequent
wheez
one
interest
medic
editori
topic
subtitl
tongueincheek
pleas
sneez
child
strategi
may
practic
clinician
abl
reassur
worri
parent
day
care
exposur
seem
result
longterm
risk
asthma
factor
contribut
develop
asthma
still
unclear
littl
doubt
viral
infect
act
potent
trigger
asthma
preschool
children
note
hrv
potent
trigger
though
hrv
seem
alik
pathogen
hrv
appear
vari
among
group
b
c
hrvc
found
studi
hospit
preschool
children
associ
asthma
often
hrva
hrvc
note
frequent
type
found
patient
present
emerg
depart
contrast
experiment
infect
type
hrva
result
wors
ill
allerg
nonallerg
subject
knowledg
circul
virul
hrv
strain
commun
could
put
clinician
alert
seriou
symptom
asthmat
patient
cold
sever
compet
classif
system
wheez
preschool
child
aim
help
prognosi
treatment
tabl
conceptu
model
one
creat
two
oppos
pole
one
pole
small
child
experi
rare
mild
wheez
acut
viral
ill
wheez
cough
episod
atopi
parent
asthma
children
appear
benefit
littl
acut
chronic
corticosteroid
therapi
viraltrigg
wheez
ill
pole
children
wheez
daili
weekli
atop
histori
parent
histori
asthma
may
chronic
control
therapi
viral
infect
children
appear
trigger
requir
step
asthma
therapi
perhap
burst
oral
corticosteroid
pole
sever
mani
children
whose
therapi
must
individu
criteria
nation
asthma
educ
prevent
program
help
select
preschool
children
may
benefit
acut
chronic
corticosteroid
guidelin
use
asthma
predict
index
specifi
wheezi
small
children
like
chronic
asthma
could
benefit
variou
form
inhal
oral
corticosteroid
therapi
owe
concern
oral
corticosteroid
form
treatment
viral
wheez
examin
preschool
children
studi
children
show
benefit
episod
highdos
inhal
steroid
viral
rti
wheez
though
advers
effect
growth
note
effect
ltra
montelukast
examin
studi
year
old
histori
intermitt
asthma
studi
show
reduct
typic
viralinduc
asthma
exacerb
children
given
ltra
daili
control
inhal
corticosteroid
ltra
option
control
chronic
asthmat
wheez
age
group
prolong
chronic
cough
viral
rti
may
problem
preschool
children
whether
asthmat
spend
consider
percentag
year
viral
rti
symptom
distress
patient
parent
year
teen
young
adulthood
tend
healthiest
year
individu
life
expand
antivir
immunolog
repertoir
help
reduc
number
annual
viral
rti
childhood
time
frequent
viral
rti
young
adult
expos
small
children
may
secondari
peak
near
acut
sinus
common
problem
age
group
sinus
known
preced
worsen
asthma
episod
acut
sinus
often
occas
cours
antibiot
entiti
viral
rhinosinus
though
far
common
previous
believ
viral
rti
produc
week
purul
discharg
radiograph
abnorm
sinu
caviti
ct
scan
acut
sinus
predominantli
initi
bacteria
least
first
week
antibioticrespons
mechan
acut
viral
sinus
becom
link
worsen
asthma
gener
associ
diseas
viral
infect
fig
adult
group
patient
asthma
diverg
sever
differ
phenotyp
like
repres
variou
diseas
asthma
often
said
syndrom
rather
one
diseas
differ
phenotyp
may
vari
respons
viral
infect
cluster
analysi
divid
asthma
patient
five
differ
group
one
group
benign
asthma
seem
wellcontrol
symptom
regardless
trigger
viral
otherwis
anoth
group
femal
preponder
obes
nonesosinophil
minim
atopi
eosinophil
inflamm
yet
high
level
symptom
respons
typic
trigger
chronic
adult
diseas
previous
unknown
caus
occasion
found
whole
part
infecti
etiolog
includ
peptic
ulcer
diseas
helicobact
pylori
polyarter
nodosa
hepat
b
c
reactiv
arthriti
shigella
chlamydia
lyme
arthriti
borrelia
burgdorferi
survey
asthma
patient
mean
age
suggest
initi
attack
start
ill
suggest
respiratori
infect
subset
tend
nonatop
may
repres
distinct
phenotyp
viral
nonvir
initi
infecti
agent
propos
adult
infecti
asthma
includ
mycoplasma
chlamydia
adenoviru
adult
rsv
reason
proof
infecti
mechan
still
pend
regardless
initi
caus
asthma
exacerb
adult
children
viral
respiratori
infect
respiratori
viru
found
least
time
adult
asthma
exacerb
frequent
childhood
acut
signific
wheez
episod
older
elderli
adult
experi
degre
immun
senesc
also
expand
specif
antivir
immun
type
viral
ill
exacerb
asthma
slightli
differ
younger
year
peak
ed
visit
asthma
admiss
adult
tend
fall
rather
decemb
januari
suggest
broader
rang
viral
trigger
fall
rhinoviru
peak
contribut
influenza
excess
morbid
older
adult
well
known
less
gener
appreci
contribut
rhinoviru
seriou
ill
concomit
heart
diseas
chronic
obstruct
pulmonari
diseas
hypertens
make
viralexacerb
asthma
complic
seriou
ill
older
adult
rhinoviru
outbreak
nurs
home
elderli
patient
result
two
third
affect
patient
lower
respiratori
tract
symptom
nearli
onethird
requir
corticosteroid
bronchodil
therapi
three
individu
seriou
morbid
includ
one
death
peak
rhinoviru
rti
may
seen
grandpar
care
small
children
consist
effect
treatment
viralcaus
respiratori
diseas
frustratingli
slow
arriv
modern
pharmacopoeia
despit
obstacl
howev
proactiv
approach
includ
vaccin
respiratori
hygien
improv
care
patient
risk
viral
ill
bronchospasm
avert
complic
sinc
time
albert
einstein
scientist
known
wari
spooki
action
distanc
particl
affect
respiratori
tract
must
first
dispers
air
enter
contact
respiratori
tissu
effect
particl
vari
size
molecul
angstrom
rang
socal
nanoparticl
larg
pollen
grain
largest
dust
particl
remain
suspend
air
air
particl
divid
sever
common
rang
studi
purpos
particul
aerodynam
diamet
less
mm
nm
fine
particl
diamet
mm
nm
ultrafin
particl
nanoparticl
diamet
mm
nm
studi
realworld
clinic
effect
individu
compon
air
pollut
challeng
sinc
compon
tend
releas
air
time
unwant
andor
unhealthi
gase
particl
make
compon
air
pollut
outdoor
air
qualiti
issu
vari
great
extent
specif
locat
depend
weather
climat
level
vehicl
traffic
type
fuel
use
energi
manufactur
unit
state
offic
air
qualiti
plan
standard
oaqp
establish
nation
ambient
air
qualiti
standard
naaq
sever
pollut
carbon
monoxid
lead
nitrogen
dioxid
ozon
sulfur
dioxid
particul
matter
air
maximum
exposur
standard
fig
studi
effect
air
pollut
health
attempt
use
statist
analysi
separ
individu
contribut
compon
pollut
addit
provocationexposur
test
perform
laboratori
mani
question
ask
viral
diseas
ask
air
pollut
initi
asthma
trigger
asthma
clearli
everyon
breath
air
pollut
get
asthma
wheez
exposur
seem
increas
risk
popul
studi
netherland
found
children
higher
exposur
trafficrel
pollut
particul
matter
like
develop
asthma
data
taiwan
children
health
studi
show
increas
preval
bronchit
symptom
among
children
longterm
exposur
outdoor
air
pollut
addit
irrit
properti
air
pollut
may
contain
immunolog
activ
particl
nanoparticl
includ
particl
diesel
exhaust
suspend
air
especi
interest
immunologist
studi
develop
asthma
propos
act
adjuv
immunomodul
diesel
particul
size
less
mm
repres
mixtur
fine
particl
nanoparticl
acut
wheez
may
trigger
exposur
high
level
pollut
gase
includ
nitrogen
dioxid
sulfur
dioxid
carbon
monoxid
burn
fossil
fuel
main
sourc
pollut
locat
nitrogen
dioxid
sulfur
dioxid
gase
diffus
rapidli
impact
upon
wet
respiratori
tract
produc
highli
irrit
acid
sulfur
dioxid
caus
respiratori
constrict
asthmat
patient
concentr
ppm
exercis
healthi
adult
begin
experienc
increas
airway
resist
ppm
even
nonasthmat
adult
develop
bronchospasm
ppm
though
level
would
highli
unusu
outdoor
air
pollut
nitrogen
oxid
especi
also
irrit
upper
lower
respiratori
tract
low
level
patient
asthma
suscept
advers
effect
higher
concentr
outdoor
associ
asthma
symptom
studi
inner
citi
children
though
mechan
action
uncertain
exposur
carbon
monoxid
citi
air
found
one
european
studi
worsen
lung
function
adult
patient
asthma
ozon
critic
import
global
health
upper
atmospher
especi
noxiou
chemic
gener
near
ground
level
ozon
produc
directli
traffic
hydrocarbon
burn
instead
combin
hydrocarbon
air
sunlight
form
secondari
pollut
ozon
high
averag
ozon
airborn
particul
matter
associ
frequent
asthma
symptom
ed
visit
hospit
stay
studi
asthma
suffer
san
joaquin
valley
california
ozon
air
pollut
shown
exacerb
asthma
children
adult
though
effect
may
greater
children
studi
emerg
depart
visit
atlanta
pediatr
asthma
show
relationship
ozon
primari
pollut
concentr
traffic
sourc
pollut
increas
ed
visit
even
rel
low
concentr
studi
particul
matter
air
quit
complex
sinc
exact
composit
vari
geograph
gener
high
level
particul
matter
long
associ
epidemiolog
studi
increas
level
respiratori
diseas
ongo
research
examin
import
particl
size
fine
versu
coars
asthma
chronic
respiratori
ill
one
studi
turkey
show
rise
asthma
admiss
air
contain
high
level
coars
particl
contrast
us
studi
find
increas
hospit
respiratori
diseas
period
high
coars
particl
level
evid
neg
effect
health
suspend
fine
particl
stronger
genet
phenotyp
differ
may
import
sensit
asthma
patient
air
pollut
risk
childhood
asthma
mexico
citi
modul
children
gene
control
respons
oxid
stress
might
occur
breath
ozon
advic
avoid
high
concentr
air
pollut
import
asthma
patient
air
pollut
like
pollen
virus
follow
season
pattern
knowledg
local
pattern
help
primari
physician
diagnosi
treatment
unit
state
daili
air
qualiti
index
aqi
comput
distribut
larg
popul
area
aqi
determin
basi
highest
pollut
day
may
consid
safe
patient
chronic
respiratori
diseas
less
green
zone
day
poor
air
qualiti
asthma
suffer
come
insid
pollut
level
typic
much
lower
indoor
ozon
level
vari
outdoor
concentr
depend
size
outdoor
air
flow
build
although
asthma
patient
continu
control
therapi
period
high
air
pollut
pretreat
control
medic
may
alway
success
budesonid
treatment
one
studi
success
prevent
ozonetrigg
function
airway
impair
test
subject
mild
persist
asthma
outdoor
air
pollut
rightli
receiv
great
deal
media
govern
attent
indoor
air
pollut
make
live
insid
hazard
well
fortun
indoor
air
problem
usual
amen
person
control
behavior
advic
air
qualiti
issu
may
occur
home
work
environ
field
occup
medicin
examin
workplac
concern
review
anoth
chapter
home
air
qualiti
typic
regul
though
pollut
may
result
sever
indoor
sourc
hydrocarbon
fuel
cours
burn
insid
well
outdoor
indoor
ga
cook
heat
stove
may
produc
high
level
associ
increas
asthma
symptom
children
good
ventil
essenti
natur
ga
burn
indoor
indoor
nitrogen
oxid
also
produc
woodburn
stove
especi
well
vent
seriou
preval
type
home
air
pollut
secondhand
environment
tobacco
smoke
et
risk
indoor
pollut
begin
utero
matern
smoke
pregnanc
associ
increas
infant
wheez
risk
respiratori
morbid
continu
increas
postnat
parent
smoke
law
regul
indoor
tobacco
smoke
one
european
countri
follow
improv
qualityoflif
score
group
asthmat
indoor
worker
also
reduct
overal
rate
hospit
childhood
asthma
note
previous
indoor
ozon
usual
much
less
outdoor
level
recent
year
though
indoor
ozon
gener
market
public
odor
control
purport
heath
benefit
us
epa
review
warn
public
potenti
hazard
ad
addit
amount
measur
air
pollut
indoor
air
chapter
examin
signific
initi
exacerb
caus
asthma
viral
respiratori
infect
lesser
extent
air
pollut
common
trigger
exacerb
may
interact
individu
affect
develop
form
asthma
causal
factor
exist
isol
rather
interact
person
attribut
patient
includ
genet
environment
background
role
virus
pollut
asthma
import
knowledg
consequ
prevent
treatment
avoid
ill
help
educ
may
given
patient
appropri
treatment
select
health
care
provid
avoid
consider
human
effort
resourc
wast
intervent
useless
harm
viral
pollut
trigger
demonstr
highli
complex
inflammatori
asthmat
respons
call
forth
mani
occas
simpli
contact
pollen
grain
allergen
respiratori
tract
sinc
much
immun
inflamm
seem
arisen
need
combat
infect
interact
asthmat
inflamm
viral
infect
natur
topic
investig
signific
advanc
medic
care
come
treatment
prevent
viral
ill
further
understand
respiratori
virus
worthi
prioriti
futur
studi
asthma
prevent
treatment
addit
natur
harm
infecti
particl
human
recent
decad
ad
mani
substanc
creation
includ
molecul
particl
constitut
indoor
outdoor
air
pollut
control
problem
import
overal
respiratori
health
import
action
advic
avail
asthma
patient
understand
anticip
respiratori
viral
infect
air
pollut
import
caus
asthma
health
care
provid
provid
superior
care
suffer
chronic
diseas
thank
albin
leong
md
denis
ryhal
bsn
help
comment
review
portion
manuscript
